BRIEF-Icecure's Next-Generation Multiprobe Cryoablation Technology Issued Notice Of Allowance From Japan's Patent OfficeNov 25 (Reuters) - Icecure Medical Ltd ICCM.O:
ICECURE'S NEXT-GENERATION MULTIPROBE CRYOABLATION TECHNOLOGY ISSUED NOTICE OF ALLOWANCE FROM JAPAN'S PATENT OFFICE
ICECURE MEDICAL LTD: TERUMO CORPORATION PLANS TO FILE FOR REGULATORY APPROVAL OF PROSENSE FOR BREAST CANCER IN 2025
Source text: ID:nPnbtmRjCa
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments